Research Presentation Sessions: Breast

RPS 2402 - Breast cancer staging and response to therapy

Lectures

1
Introduction by the moderator

Introduction by the moderator

04:00Mirjan Nadrljanski, Belgrade / RS

2
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade ductal carcinoma in situ of the breast

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade ductal carcinoma in situ of the breast

08:00Daniela Ballerini, Pavia / IT

3
Diagnostic performance of imaging modalities for response of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis

Diagnostic performance of imaging modalities for response of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis

08:00Thiemo van Nijnatten, Maastricht / NL

4
Prediction of primary tumour and axillary lymph node response to neoadjuvant systemic therapy with dedicated breast 18F-FDG PET/MRI in breast cancer

Prediction of primary tumour and axillary lymph node response to neoadjuvant systemic therapy with dedicated breast 18F-FDG PET/MRI in breast cancer

08:00Thiemo van Nijnatten, Maastricht / NL

5
Role of contrast-enhanced mammography (CEM) as a promising tool in preoperative staging of breast cancer

Role of contrast-enhanced mammography (CEM) as a promising tool in preoperative staging of breast cancer

08:00Carlotta Rucci, Rome / IT

6
Preoperative staging of invasive lobular carcinoma (ILC): contrast-enhanced mammography (CEM) as alternative for breast MRI?

Preoperative staging of invasive lobular carcinoma (ILC): contrast-enhanced mammography (CEM) as alternative for breast MRI?

08:00Marc Lobbes, Sittard-Geleen / NL

7
The kinetic and morphologic changes of conventional and ultrafast dynamic contrast-enhanced MRI in breast cancer patients after neoadjuvant chemotherapy-preliminary report

The kinetic and morphologic changes of conventional and ultrafast dynamic contrast-enhanced MRI in breast cancer patients after neoadjuvant chemotherapy-preliminary report

08:00Ah Young Park, Seongnam-si / KR